Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of April 2026. The report announces the scheduling of the Company's Annual General Meeting of Shareholders to be held on May 28, 2026, at 3:00 p.m. Israel time at its principal executive offices in Ramat Gan, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely as a notice regarding shareholder meeting logistics and does not contain financial performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing. The document focuses exclusively on corporate governance procedures related to the upcoming shareholder meeting.
Guidance, Outlook, and Management Commentary
There is no financial guidance, outlook, or management commentary regarding business operations in this filing. The report details the furnishing of three specific documents for the Annual General Meeting: a Notice and Proxy Statement (Exhibit 99.1), a Proxy Card for ordinary share holders (Exhibit 99.2), and a Voting Instruction Card for American Depositary Shareholders (Exhibit 99.3).
Key Facts for Investor Verification
- Annual General Meeting Date: May 28, 2026.
- Meeting Time: 3:00 p.m. Israel time.
- Meeting Location: 26 Ben Gurion Street, Ramat Gan, Israel.
- Voting Materials: Proxy cards and voting instruction cards are available for shareholders unable to attend in person.
- Financial Data: This filing contains no financial results; investors should refer to the Company's Form 20-F or other financial reports for performance metrics.